tobramycin has been researched along with lactoferrin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McCray, PB; Singh, PK; Tack, BF; Welsh, MJ | 1 |
Greenberg, EP; Parsek, MR; Singh, PK; Welsh, MJ | 1 |
Andrés, MT; Fierro, JF; Pérez, F; Viejo-Diaz, M | 1 |
Coutermarsh, B; Moreau-Marquis, S; Stanton, BA | 1 |
Marshall, LJ; Oguejiofor, W; Price, R; Shur, J | 1 |
5 other study(ies) available for tobramycin and lactoferrin
Article | Year |
---|---|
Synergistic and additive killing by antimicrobial factors found in human airway surface liquid.
Topics: Anti-Bacterial Agents; Defensins; Drug Interactions; Drug Synergism; Escherichia coli; Extracellular Space; Humans; Kinetics; Lactoferrin; Milk, Human; Muramidase; Proteinase Inhibitory Proteins, Secretory; Proteins; Recombinant Proteins; Respiratory Mucosa; Secretory Leukocyte Peptidase Inhibitor; Tobramycin | 2000 |
A component of innate immunity prevents bacterial biofilm development.
Topics: Biofilms; Chronic Disease; Conalbumin; Dose-Response Relationship, Drug; Humans; Hydrogen Peroxide; Immunity, Innate; Iron; Iron Chelating Agents; Lactoferrin; Pseudomonas aeruginosa; Tobramycin | 2002 |
Antibiotic tolerance induced by lactoferrin in clinical Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Topics: Anti-Bacterial Agents; Cystic Fibrosis; Drug Resistance, Bacterial; Humans; Lactoferrin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2005 |
Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing on cystic fibrosis airway epithelial cells.
Topics: Anti-Bacterial Agents; Aztreonam; Biofilms; Cells, Cultured; Colony Count, Microbial; Drug Combinations; Drug Synergism; Epithelial Cells; Humans; Lactoferrin; Microbial Viability; Pseudomonas aeruginosa; Thiocyanates; Tobramycin | 2015 |
Investigation of the enhanced antimicrobial activity of combination dry powder inhaler formulations of lactoferrin.
Topics: Anti-Infective Agents; Apoproteins; Biofilms; Cell Survival; Drug Compounding; Drug Synergism; Gentamicins; Lactoferrin; Powders; Pseudomonas aeruginosa; Tobramycin | 2016 |